Responses

Download PDFPDF

Dietary products used in infants for treatment and prevention of food allergy.
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Dietary products used in infants for treatment and prevention of food allergy
    Dear Editor

    We agree with the letter from Professor Koletzko suggesting that more studies in this field are necessary (Arch Dis Child Rapid Response 6 June 2000). However, Table 4 of my study detailed all the data of the "other authors" and tried to make a mean among all such data. Since Sampson et al documented a 0% prevelence of sensitisation to soy, we concluded that about "80-100%" of children.

    Professor...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Response to Prof. Analado Cantani

    The comment of Dr. Cantani (Arch Dis Child rapid response, 2 June 2000) is interesting and reemphasizes our conclusion drawn in the joint statement of ESPGHAN and ESPACI (Arch Dis Child 1999;81:80-84) that in view of controversial judgements more studies are required to further elucidate the effects of soy protein based formulas in infants with food allergies. Although Cantani claims that 80-100% of infants with IgE media...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Dietary products used in infants for treatment and prevention of food allergy
    Dear Editor

    In a not cited paper published by Pediatric Allergy Immunology I have detailed everything about soy formulas (SFs). Children with atopic dermatitis fare well on SFs, those with colitis/enterocolitis have reactions to soy, but Burks demonstrated that these are not IgE-mediated, therefore it is improper to classify such reactions as allergenic.

    In Table 4, 19.8% of children (mean) reacted to SFs, but...

    Show More
    Conflict of Interest:
    None declared.